The risk of hypoglycemia due to insulin therapy is low, -Strong in favor-. Treatment of CFRD with insulin could result in an improvement in fasting and postprandial blood sugar levels more than in the HbA1c value, -Strong in favor-. The gene discussed is INS; the disease is Hypoglycemia.